Hemofarm is the leader on the pharmaceutical market of Serbia. Taking up over 70% of the total exports of pharmaceutical products, the Vršac-based company is at the same time the largest Serbian exporter of drugs. Hemofarm manufactures about 6.6 billion tablets and capsules annually. It operates on four continents and it has a team of over 3,600 employees. In addition to being present on 34 markets around the World, Hemofarm is among the largest pharmaceutical manufacturers in this region.

The company is committed to permanent innovation. In addition to researching and developing modern pharmaceutical products, Hemofarm pays special attention to sustainable. It is in compliance with the BSCI Code of social responsibility and respect for human rights, with one of the highest degrees of compliance of all the companies operating in Serbia.